-+ 0.00%
-+ 0.00%
-+ 0.00%

Aramark Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Simply Wall St·11/19/2026 10:34:07
Listen to the news

Investors in Aramark (NYSE:ARMK) had a good week, as its shares rose 5.7% to close at US$56.85 following the release of its yearly results. Revenues were in line with forecasts, at US$20b, although statutory earnings per share came in 10% below what the analysts expected, at US$1.62 per share. Following the result, the analysts have updated their earnings model, and it would be good to know whether they think there's been a strong change in the company's prospects, or if it's business as usual. We thought readers would find it interesting to see the analysts latest (statutory) post-earnings forecasts for next year.

earnings-and-revenue-growth
NYSE:ARMK Earnings and Revenue Growth November 19th 2026

Taking into account the latest results, the most recent consensus for Aramark from 16 analysts is for revenues of US$22.0b in 2027. If met, it would imply a meaningful 9.5% increase on its revenue over the past 12 months. Statutory earnings per share are predicted to bounce 49% to US$2.45. In the lead-up to this report, the analysts had been modelling revenues of US$21.9b and earnings per share (EPS) of US$2.49 in 2027. So it's pretty clear that, although the analysts have updated their estimates, there's been no major change in expectations for the business following the latest results.

Check out our latest analysis for Aramark

The analysts reconfirmed their price target of US$67.34, showing that the business is executing well and in line with expectations. Fixating on a single price target can be unwise though, since the consensus target is effectively the average of analyst price targets. As a result, some investors like to look at the range of estimates to see if there are any diverging opinions on the company's valuation. The most optimistic Aramark analyst has a price target of US$75.00 per share, while the most pessimistic values it at US$47.00. Analysts definitely have varying views on the business, but the spread of estimates is not wide enough in our view to suggest that extreme outcomes could await Aramark shareholders.

Of course, another way to look at these forecasts is to place them into context against the industry itself. The analysts are definitely expecting Aramark's growth to accelerate, with the forecast 9.5% annualised growth to the end of 2027 ranking favourably alongside historical growth of 7.8% per annum over the past five years. Other similar companies in the industry (with analyst coverage) are also forecast to grow their revenue at 9.3% per year. Aramark is expected to grow at about the same rate as its industry, so it's not clear that we can draw any conclusions from its growth relative to competitors.

The Bottom Line

The most important thing to take away is that there's been no major change in sentiment, with the analysts reconfirming that the business is performing in line with their previous earnings per share estimates. They also reconfirmed their revenue estimates, with the company predicted to grow at about the same rate as the wider industry. The consensus price target held steady at US$67.34, with the latest estimates not enough to have an impact on their price targets.

Following on from that line of thought, we think that the long-term prospects of the business are much more relevant than next year's earnings. We have estimates - from multiple Aramark analysts - going out to 2029, and you can see them free on our platform here.

That said, it's still necessary to consider the ever-present spectre of investment risk. We've identified 1 warning sign with Aramark , and understanding it should be part of your investment process.